Researchers used metatranscriptomics to compare bacterial activity, virulence, and antimicrobial resistance in acute apical abscesses versus asymptomatic apical periodontitis. Samples from 20 patients—10 with acute abscesses and 10 with asymptomatic cases—were analyzed using RNA sequencing on the NovaSeq 6000 platform. The study aimed to uncover differences in gene expression and resistance profiles between the two conditions. By examining the active microbiome and resistome, the team sought to better understand the pathogenic mechanisms driving acute infections. This approach provides deeper insight into the functional roles of bacteria in endodontic disease, potentially informing more targeted treatments for acute apical abscesses. The findings could help differentiate between acute and chronic infections at the molecular level. [[TRANSITION]] The global microbiome census has a blind spot—and it's bigger than anyone realized. A new analysis in Nature Microbiology reveals that current genome-based surveys, which rely on isolate genomes and metagenome-assembled genomes, are missing the majority of discoverable prokaryotic species diversity. The study estimates that only 20 to 50 percent of total discoverable species are captured by existing methods, with the rest hiding in plain sight within unassembled metagenomic contigs. The problem stems from how we've been cataloging microbial life. Traditional approaches depend on either cultivating organisms in the lab or assembling their genomes from environmental samples. Both methods have limitations. Cultivation captures only a tiny fraction of microbes, while assembly often fails for organisms with low abundance or high genomic complexity. The researchers tackled this by analyzing over 200,000 metagenomic samples from diverse environments—everything from soil and ocean to human gut and extreme habitats. What they found was striking: vast amounts of genetic diversity exist in unassembled reads that never make it into reference databases. These unbinned contigs represent species that are either too rare, too novel, or too fragmented to assemble into complete genomes. The study developed new computational approaches to identify species-level diversity directly from these unassembled sequences, revealing that uncultivated phyla—entire branches of the tree of life with no cultured representatives—are particularly underrepresented. The implications are profound. If we're missing half or more of discoverable species, our understanding of microbial ecosystems, their functions, and their evolutionary relationships is fundamentally incomplete. This matters for everything from predicting how microbiomes respond to environmental change to discovering new enzymes for biotechnology. The study also highlights that the "known" tree of life is more like a sapling with vast unseen roots—and those roots are where much of microbial innovation may be hiding. [[TRANSITION]] Early weaning is a common practice in lamb production to improve efficiency, but it comes with a major downside: the intestinal barrier often becomes compromised. That's a problem because a weakened gut lining can lead to inflammation, poor nutrient absorption, and even systemic health issues. Researchers have been looking for ways to counteract this, and in this study, they turned to a natural compound found in green tea—epigallocatechin, or EGC. The team tested EGC supplementation in weaned lambs, using a combination of metagenomics, metabolomics, and intestinal transcriptomics to get a full picture of what was happening in the gut. What they found was a clear improvement in intestinal barrier function. The lambs receiving EGC showed better growth performance and healthier gut tissue compared to controls. But the real insight came from digging into the mechanisms. The researchers discovered that EGC was influencing the gut microbiota in a way that boosted the production of short-chain fatty acids—particularly butyrate. These metabolites are known to support gut health, but here they seemed to be part of a larger regulatory loop. The EGC-driven changes in the microbiota activated an IL-17/PPAR signaling axis in the intestinal tissue. IL-17 is a pro-inflammatory cytokine, but in this context, its activity—balanced by PPAR signaling—appeared to promote repair and maintenance of the gut barrier rather than inflammation. This is a nuanced finding: instead of simply suppressing immune activity, EGC seems to help the gut use immune signaling in a constructive way. The study suggests that dietary EGC could be a practical, natural strategy to support intestinal health in early-weaned lambs, potentially improving both welfare and production outcomes. The available text does not provide details on the exact dosage or long-term effects, but the mechanistic clarity here opens the door for further optimization in livestock management. [[TRANSITION]] A sweeping new study in Cell maps the planetary microbiome, revealing that generalist microbes—species capable of thriving in multiple habitats—are the primary drivers of gene flow across Earth's ecosystems. By analyzing microbiomes from vastly different environments, researchers found that these microbial generalists facilitate the exchange of genetic material, linking disparate habitats and sustaining global biogeochemical cycles. This work challenges the traditional focus on isolated ecosystems, highlighting instead a connected microbial network that underpins life on Earth. The findings underscore the importance of microbial dispersal, both natural and human-driven, in shaping planetary-scale ecological processes. This study offers a new framework for understanding how microbiomes function as an integrated, global system. [[TRANSITION]] A new study in Gut Microbes reveals that the gut microbiome may help predict recovery after lung cancer surgery. Researchers found that the prognostic nutritional index, or PNI, which measures a patient's nutritional and immune status, is linked to specific gut microbes. In patients with early-stage non-small cell lung cancer, these microbial patterns could signal who is more likely to have better outcomes after surgery. The findings suggest that analyzing gut bacteria alongside PNI might offer a new way to assess prognosis and personalize care for lung cancer patients. This work highlights the growing role of the microbiome in cancer recovery and could lead to more targeted, microbiome-informed treatment strategies. [[TRANSITION]] Spaceflight is not just hard on astronauts' bones and muscles—it turns out it's also hard on their gut microbes. A new case study published in 3 Biotech shows that the extreme conditions of space—cosmic radiation, microgravity, and the psychological stress of confinement—can significantly disrupt the composition and function of the gut microbiota. The gut microbiome is increasingly recognized as a key player in human health, influencing not just digestion but also metabolism, immune function, and even behavior. In space, however, this delicate ecosystem is thrown off balance. The study found that astronauts experience shifts in microbial diversity, with some beneficial bacteria declining and potentially harmful ones increasing. These changes can have downstream effects on nutrient absorption, immune resilience, and even mental health—critical concerns on long-duration missions to the Moon or Mars. What makes this research particularly relevant is that it's not just about cataloging changes—it's about finding ways to counteract them. The authors review evidence from both spaceflight and ground-based analog studies, such as bed rest and isolation experiments, to identify potential countermeasures. These include tailored prebiotics and probiotics, personalized nutrition plans, and even engineered synbiotics designed to stabilize the microbiome under space conditions. One of the key takeaways is that maintaining microbial homeostasis in space isn't just about adding supplements—it's about understanding the unique stressors of the space environment and how they interact with the microbiome. For example, radiation can damage microbial DNA, while microgravity may alter gut motility and nutrient availability. Confinement and stress can shift the balance toward inflammation-associated microbes. The study also highlights the need for real-time monitoring of astronauts' microbiomes during missions, using portable sequencing tools and biosensors. This would allow for dynamic adjustments to diet and supplementation, rather than relying on pre-flight planning alone. While the research is still in the early stages, it points toward a future where space medicine includes microbiome management as a core component of astronaut health. As missions get longer and more ambitious, keeping the gut microbiome in balance could be just as important as keeping the spacecraft in orbit. [[TRANSITION]] The available text does not provide details on the core claim, method, key evidence, why it matters, limitations, or terms for a specific study. The provided input is a list of article references and citations, not the full text of a single article to analyze. Without the actual research article text, it's not possible to extract the study's main findings, methodology, or significance. The references listed appear to be related works on topics like gut microbiome, metagenomics, and animal nutrition, but no specific study is described in the input. To create a deep-dive segment, the full text of the primary research article would be needed to accurately summarize its novel contributions and implications. [[TRANSITION]] New research from MedComm reveals that children with recent-onset type 1 diabetes can be grouped into distinct subtypes based on their gut microbiome profiles. Using unsupervised clustering of multi-omics data, scientists identified microbiome-based clusters that correlate with differences in glycemic control. This suggests that gut bacteria may play a role in shaping how well young patients manage their blood sugar after diagnosis. The findings point to potential biological mechanisms behind the well-known variability in diabetes outcomes among children. By uncovering these microbiome-linked subtypes, the study opens the door to more personalized approaches in managing type 1 diabetes in youth, potentially improving long-term care strategies. [[TRANSITION]] Hirschsprung's disease is a congenital disorder where the intestines lack nerve cells, leading to severe motility problems. The cause has been unclear, but this new study suggests the gut microbiota, immune system, and nervous system are all involved in a way we hadn't seen before. The researchers analyzed stool samples from 30 children with Hirschsprung's disease and 30 healthy controls. They found that the gut microbiome in Hirschsprung's patients was significantly altered. One bacterium, Gordonibacter, was much more abundant in affected children. This is notable because Gordonibacter is known to produce urolithins—compounds that can influence inflammation and immune responses. Looking deeper, the team examined immune cells in intestinal tissue. They discovered that regulatory T cells, which normally keep inflammation in check, were dysfunctional in Hirschsprung's patients. These cells showed reduced expression of key markers and impaired ability to suppress inflammation. The researchers linked this dysfunction to the altered microbiome, particularly the overabundance of Gordonibacter. But the story doesn't stop there. The study also found that a protein called S100A11, which is involved in neural development and repair, was abnormally expressed in the intestines of Hirschsprung's patients. S100A11 is known to be influenced by immune signaling, suggesting a chain reaction: microbiome changes → immune dysfunction → neural impairment. This work proposes a microbiota-immune-neural axis in Hirschsprung's disease. The idea is that an imbalanced gut microbiome, especially high levels of Gordonibacter, disrupts regulatory T cell function, which in turn affects proteins like S100A11, impairing the development or maintenance of intestinal nerves. The available text does not provide details on the specific methods used to measure these changes, nor does it report statistical significance or effect sizes. It also doesn't describe any interventions or therapeutic implications. However, the findings suggest that targeting the gut microbiome or immune system could be a new avenue for treating or even preventing Hirschsprung's disease. This study is significant because it connects three systems—microbiome, immunity, and the nervous system—in a way that could explain the root cause of a complex congenital disorder. If these findings hold up, they could open the door to microbiome-based therapies for Hirschsprung's disease, potentially improving outcomes for affected children. [[TRANSITION]] A new global database called MicrobeAtlas is transforming our understanding of Earth's microbial ecosystems by integrating environmental DNA sequencing data from across the planet. Published in Cell, this comprehensive resource addresses the challenge of disparate sequencing methods by standardizing microbiome data from diverse environments, from deep subsurface habitats to mountaintops. The database enables researchers to identify global patterns in microbial diversity and ecology across different biomes and conditions. By creating a unified framework for microbiome research, MicrobeAtlas facilitates universal insights into how microorganisms function in various ecosystems and their roles in planetary health. [[TRANSITION]] A new study from Cell Biochemistry and Function reveals that elevated serum sodium and the presence of gut bacteria Klebsiella are both positively associated with osteoporosis in humans. Researchers in Hainan, China, compared gut microbial profiles and serum markers between osteoporosis patients and healthy controls, finding that higher sodium levels and Klebsiella abundance were linked to lower bone density. This suggests that both dietary sodium and specific gut microbes may play a role in bone health, adding to growing evidence that gut microbiota dysbiosis contributes to osteoporosis. The findings highlight potential new targets for prevention and treatment, though further research is needed to clarify the mechanisms and causality behind these associations. [[TRANSITION]] A new study in Environmental Science & Technology traces how cyanophages—viruses that infect marine cyanobacteria—coevolve with their hosts by comparing field metagenomes to lab-generated mutant genomes. Researchers found that viral genes adapt rapidly to exploit host metabolic pathways, while hosts evolve resistance mechanisms, creating a dynamic evolutionary arms race. This work sheds light on the ecological balance of ocean microbial communities and the role of viruses in shaping primary productivity. The findings highlight the importance of viral-host interactions in marine ecosystems and could inform models of carbon cycling and climate regulation. Source: Environmental Science & Technology. [[TRANSITION]] New research in Neurogastroenterology and Motility reveals that short-chain fatty acids, produced by gut microbes, can slow down colon movement by activating specific nerve cells. The study shows SCFAs work through free fatty acid receptors 2 and 3, which are found on both hormone-producing gut cells and enteric nerves. This interaction delays colonic motility, suggesting a direct link between gut bacteria byproducts and intestinal nerve activity. The findings highlight how microbial metabolites influence gut-brain signaling and could inform new treatments for motility disorders. [[TRANSITION]] Weaning is a critical and stressful transition for piglets, often leading to intestinal injury that impacts growth and health. This review explores how gut microbiota regulates intestinal stem cell function and how disruptions during weaning can be addressed through targeted nutritional interventions. Intestinal stem cells are essential for maintaining the intestinal lining, constantly renewing the epithelium to repair damage and maintain barrier function. The gut microbiota plays a key role in regulating these stem cells, influencing their proliferation, differentiation, and overall function. However, the stress of weaning—marked by abrupt dietary and environmental changes—can disrupt this delicate balance, leading to dysbiosis and impaired ISC function, which in turn causes intestinal injury. The review highlights that targeted nutritional strategies can help restore this balance. By modulating the gut microbiota through specific dietary interventions, it's possible to support ISC function and promote tissue repair. This approach offers a promising avenue for alleviating weaning-associated intestinal injury in piglets, potentially improving their health and growth performance. While the review underscores the importance of the microbe-ISC interaction, it does not provide specific details on the methods, key evidence, or limitations of the studies discussed. Nonetheless, the findings suggest that understanding and leveraging this interaction could lead to more effective strategies for managing intestinal health in weaned piglets. This could have significant implications for animal welfare and agricultural productivity. [[TRANSITION]] A new study in Gut Microbes reveals that transplanting gut microbes from stunted children into mice fed a high-fat, high-fructose diet leads to metabolic dysfunction. Stunting, which affects 48-56% of school-aged children globally, is linked to later weight gain and chronic disease. Researchers found that the gut microbiome of undernourished children may predispose them to obesity when exposed to calorie-rich environments. This suggests that early-life malnutrition can have lasting metabolic effects through microbial changes. The findings highlight the complex interplay between nutrition, gut microbes, and long-term health, emphasizing the need for interventions targeting both diet and microbiome in stunted children. [[TRANSITION]] A new review in Gut Microbes highlights that inflammatory bowel disease involves more than just bacterial dysbiosis—it also includes disruptions in the gut virome and mycobiome. While IBD is known for immune dysregulation and epithelial barrier dysfunction, the study emphasizes that viruses and fungi in the gut microbiome play underappreciated roles in disease progression. The review points out that alongside the depletion of beneficial short-chain fatty acid producers and the rise of pathobionts, alterations in viral and fungal communities may contribute to chronic inflammation and relapse. This broader view of the gut ecosystem could open new avenues for diagnosis and treatment, urging researchers to look beyond bacteria when studying IBD. [[TRANSITION]] The built environment microbiome has been studied for years, but one big question has always lingered: do the patterns researchers find actually hold up across different buildings, different times, and different labs? A new analysis from bioRxiv tackles this head-on by integrating data from four separate studies, each with its own sequencing protocols, sampling designs, and environmental contexts. The goal was to see whether the microbial fingerprints of indoor spaces are consistent enough to be meaningful beyond any single study. What they found is striking. Despite the methodological differences and the diversity of buildings—ranging from offices to homes—the bacterial communities in these environments showed strong, reproducible patterns. Floors, for example, were consistently enriched with soil-associated taxa. That makes intuitive sense: we track dirt in from outside, and those microbes settle where we walk. On the other hand, hands and hand-contact surfaces—like doorknobs, light switches, and keyboards—were dominated by bacteria typically found on human skin. This wasn't just a one-off observation in a single study; it held true across all four datasets. This reproducibility is important because it suggests that the built environment microbiome isn't just a chaotic mix of random microbes. Instead, there are predictable ecological rules at play, shaped by human behavior and the physical layout of spaces. The fact that these patterns persist despite differences in sequencing depth, primer choice, and lab protocols means that microbiome studies of indoor environments can be more confidently compared and combined in the future. One caveat: the analysis focused on bacteria, so we don't yet know if similar reproducibility exists for fungi, viruses, or other microbes. Also, while the study confirms broad patterns, it doesn't pinpoint every factor that might tweak these communities—things like ventilation, cleaning frequency, or seasonal changes could still introduce variation. Still, this work is a big step forward. It shows that, even in the messy, variable world of indoor microbiomes, there are reliable signals waiting to be discovered—if we're willing to look across studies and synthesize the data. [[TRANSITION]] Microbial communities are everywhere in the human body, from the gut to the mouth to the vagina, and understanding their composition is key to linking them to health and disease. Traditionally, researchers have classified these communities into discrete groups called community state types, or CSTs, using nearest-neighbor methods. These approaches work by comparing a new sample to existing reference samples and assigning it to the closest match. But nearest-neighbor methods have a problem: they struggle with the noise, high dimensionality, and non-linear patterns that are common in microbiome data. That's where StrataBionn comes in. StrataBionn is a new supervised classification framework built around an artificial neural network, or ANN. The authors packaged this as a tool and trained it on large-scale vaginal microbiome datasets. They then compared its performance directly to VALENCIA, a popular nearest-neighbor tool, and also to a Random Forest classifier. The ANN-based approach consistently outperformed both, especially in accuracy and robustness when dealing with noisy or complex data. But the real test of a method is whether it generalizes. So the team extended StrataBionn to classify oral microbiomes as well. The results held up: the ANN framework maintained high accuracy and stability across both vaginal and oral datasets, suggesting it's not just a niche solution but a broadly applicable tool. StrataBionn also includes features for visualizing classification boundaries in feature space and for performing perturbation analysis on trained models. This means researchers can not only classify samples but also understand how confident the model is and how it responds to changes in the data. The available text does not provide details on the specific architecture of the ANN, the exact size of the datasets, or the precise accuracy metrics. However, the consistent outperformance of nearest-neighbor and Random Forest methods, combined with successful generalization to a new body site, makes a strong case for StrataBionn as a next-generation tool for microbiome classification. If you're working with microbial community data and need reliable, interpretable CST assignments, StrataBionn looks like a significant step forward. [[TRANSITION]] Wharf roaches are small crustaceans that live along coastlines and often ingest plastic debris, particularly expanded polystyrene foam. Researchers in Japan exposed these animals to EPS in the lab and tracked changes in their gut microbiome and gene expression. The results showed that EPS ingestion altered the abundance of gut microbes and changed the expression levels of more than 400 host genes. Among the microbes that increased after EPS exposure were several archaea—*Haloquadratum*, *Halalkalicoccus*, and *Methanospillum*—as well as the eukaryote *Volvox* and two virus groups: *Varicellovirus* and T4-like viruses. To understand which of these changes were most likely to be driving the observed effects, the team used covariance structure analysis, a statistical method that infers causal relationships between variables. This analysis pointed to the increased viruses and methanogens as key causal factors linked to EPS exposure. Methanogens are microbes that produce methane, a potent greenhouse gas, as a metabolic byproduct. The finding that EPS ingestion boosts their abundance in the gut suggests a possible pathway by which plastic pollution could contribute to increased methane emissions in coastal ecosystems. The rise in viral abundance also raises questions about how plastic ingestion might activate or alter viral communities in marine organisms. The study builds on earlier field observations by providing experimental evidence that EPS directly disrupts the gut environment of a coastal crustacean. It also highlights the potential of wharf roaches as bioindicators for plastic pollution impacts. However, the available text does not specify the sample sizes, duration of exposure, EPS concentration, or detailed control conditions. It also does not address the functional consequences of the altered gene expression for roach health or how these lab findings might translate to complex field environments. Still, the work offers a mechanistic link between plastic ingestion and shifts in gut ecology that could have broader environmental implications. [[TRANSITION]] The human microbiota is not just a passive passenger in our bodies—it's a dynamic biological system that constantly communicates with us through metabolic, immunological, and neuroendocrine pathways. When this ecosystem becomes disrupted, a condition known as dysbiosis, it can drive the onset and progression of numerous chronic diseases. A comprehensive review in Antonie van Leeuwenhoek consolidates current evidence showing how microbiota-driven mechanisms influence cardiovascular, metabolic, neurological, and autoimmune disorders. In cardiovascular disease, dysbiosis can promote atherosclerosis through several pathways. Certain gut bacteria produce metabolites like trimethylamine N-oxide, or TMAO, from dietary choline and carnitine. TMAO accelerates plaque formation in arteries. Additionally, bacterial lipopolysaccharides can trigger low-grade systemic inflammation, damaging blood vessel walls. The review highlights that specific microbial signatures—such as reduced diversity and overgrowth of pro-inflammatory species—are consistently found in patients with heart disease. Metabolic disorders like obesity and type 2 diabetes also show strong microbiota links. Dysbiosis alters energy harvest from food, increases intestinal permeability, and promotes insulin resistance. For example, an imbalance between Firmicutes and Bacteroidetes phyla can enhance calorie extraction from the diet. Moreover, short-chain fatty acids produced by beneficial bacteria normally help regulate glucose metabolism and satiety. When these bacteria decline, metabolic control worsens. Neurological conditions are increasingly tied to the gut-brain axis. The microbiota influences neurotransmitter production, immune signaling, and even the integrity of the blood-brain barrier. In Parkinson's disease, certain bacterial species are overrepresented, and their metabolites may contribute to alpha-synuclein aggregation. In multiple sclerosis, dysbiosis can skew immune responses toward autoimmunity, attacking the nervous system. Autoimmune diseases like rheumatoid arthritis and inflammatory bowel disease also show microbiota-driven mechanisms. Dysbiosis can breach intestinal barriers, allowing bacterial antigens to enter circulation and trigger inappropriate immune activation. Specific pathobionts—bacteria that become harmful under certain conditions—can directly stimulate inflammatory pathways. The review emphasizes that while these connections are well-documented, causality is harder to prove. Most evidence comes from correlation studies in humans and mechanistic experiments in animals. Still, the convergence of findings across multiple disease types suggests that targeting the microbiota—through diet, probiotics, or targeted antimicrobials—could become a powerful therapeutic strategy. The challenge now is translating this understanding into precise, personalized interventions that restore microbial balance without unintended consequences. [[TRANSITION]] The human gut microbiome plays a critical role in maintaining host health and homeostasis, and current literature suggests a bidirectional relationship between microbiome ecology and host well-being. DNA metabarcoding has emerged as a powerful tool for investigating microbiome imbalances, or dysbiosis. While the prokaryotic microbiome has been extensively studied, the fungal component, known as the mycobiota, remains less understood despite its potential impact on health. A new study published in BioData Mining uses machine learning to analyze the healthy human gut mycobiota landscape using ITS1 DNA metabarcoding data. The research team applied advanced computational methods to characterize the fungal communities present in healthy individuals, aiming to establish a baseline for what constitutes a normal gut mycobiota. The study leveraged ITS1, a region of fungal ribosomal DNA commonly used for species identification, to sequence fungal DNA from stool samples. By applying machine learning algorithms, the researchers were able to classify and quantify the fungal taxa present, revealing patterns and diversity within the healthy gut mycobiome. One of the key findings is the identification of core fungal taxa that consistently appear across healthy individuals, suggesting a stable mycobiota component. The machine learning approach also highlighted potential biomarkers for gut health, which could be useful for diagnosing dysbiosis or related conditions in the future. This work is significant because it fills a gap in our understanding of the gut ecosystem. Most microbiome research has focused on bacteria, but fungi may play equally important roles in digestion, immune function, and disease prevention. By establishing a reference map of the healthy gut mycobiota, this study provides a foundation for future research into fungal contributions to health and disease. The available text does not provide details on the specific machine learning models used or the exact fungal species identified. However, the integration of DNA metabarcoding with machine learning represents a promising direction for microbiome research, offering more precise and scalable analysis than traditional methods. [[TRANSITION]] The available text does not provide details on the diagnostic model, its methodology, or key findings. The provided content consists solely of a list of citations and references, not the full article text. Without access to the actual study, it is not possible to describe the specific approach, evidence, or significance of the work. The text does not contain information about how the model distinguishes colonization from pneumonia, what data it uses, or why this matters clinically. All core elements typically covered in a deep-dive—such as the diagnostic model's design, the role of pulmonary microbiota and host gene expression, and the study's limitations—are absent from the provided input. To accurately summarize this research, the full article text would be required. [[TRANSITION]] This segment is based on a citation list, not the full text of a single article. The available text does not provide details on the core claim, method, key evidence, or why it matters. Without the full article text, it is not possible to analyze the specific findings about Lactobacillus reuteri MRD01 and its effects on dextran sulfate sodium-induced colitis in male mice. The citation references a study published in Antonie van Leeuwenhoek, but the actual content describing the probiotic strain's mechanism, experimental design, or results is not included in the provided input. Therefore, no deep-dive segment can be written from this source alone. [[TRANSITION]] Sheng Jiangsan, a traditional Chinese medicine formula approved for treating wind-heat common cold, may help alleviate influenza-induced acute lung injury by regulating gut microbiota, specifically Lactobacillus murinus. Researchers found that SJS exhibits broad-spectrum antiviral and anti-inflammatory effects, but its precise mechanisms were unclear. This study suggests that modulating gut bacteria and their metabolites plays a significant role in protecting the lungs from influenza damage. By influencing Lactobacillus murinus, SJS appears to reduce inflammation and support lung health during viral infections. These findings, published in the Journal of Ethnopharmacology, highlight the potential of gut-lung axis interventions in treating respiratory illnesses and offer new insights into the therapeutic actions of traditional remedies. [[TRANSITION]] Microcystin-LR disrupts gut metabolic homeostasis in grass carp by remodeling the microbiota-metabolite axis, according to a study in Comparative Biochemistry and Physiology. Researchers exposed fish to 5 and 10 μg/L of the toxin and used integrated histological, biochemical, molecular, microbiomics, metabolomic, and cellular analyses. The toxin impaired gut mucosal integrity and altered microbial communities, shifting metabolite profiles linked to energy metabolism and immune function. These changes suggest MC-LR interferes with the gut's ability to maintain metabolic balance, potentially compromising fish health. The findings highlight how environmental cyanotoxins can disrupt host-microbe interactions and metabolic homeostasis in aquatic species, with implications for aquaculture and ecosystem health. [[TRANSITION]] A new study in the International Dental Journal reveals that patients with oral lichen planus have a disrupted salivary fungal community, suggesting a previously underexplored link between fungal dysbiosis and this chronic inflammatory oral condition. While bacterial imbalances in OLP have been well documented, this research highlights that fungal populations in saliva also show significant alterations, potentially influencing disease progression and malignant risk. The findings underscore the need to consider both bacterial and fungal components when studying oral microbiome changes in OLP. This could open new avenues for diagnosis and treatment by targeting fungal community imbalances alongside bacterial ones. The study calls for further investigation into how these fungal shifts contribute to OLP pathogenesis and patient outcomes. [[TRANSITION]] A new study in the International Journal of Biological Macromolecules suggests that a polysaccharide from the traditional Chinese herb Atractylodes macrocephala may protect against cognitive decline caused by weightlessness. The compound, called AMP1-1, appears to work by modulating the microbiota-gut-brain axis, a pathway linking gut health to brain function. While the full details of the study's methods and results are not provided, the research highlights the potential of natural compounds in addressing cognitive issues linked to altered gravity environments. This could have implications for astronauts or others exposed to microgravity, offering a possible preventive or therapeutic strategy rooted in traditional medicine. [[TRANSITION]] A new study in the Journal of Genetics and Genomics suggests that the gut bacterium Parabacteroides johnsonii may help slow age-related decline in ovarian function. Researchers used Mendelian randomization to identify microbial links to ovarian aging, then validated findings experimentally. The work highlights a potential causal role for gut microbiota in reproductive health, pointing to probiotics as a future strategy for mitigating fertility loss in aging. While the exact mechanisms remain to be fully mapped, the findings open a promising avenue for microbiome-based interventions in reproductive aging. [[TRANSITION]] A new study in The Journal of Physiology reveals that exercise training boosts mitochondrial biogenesis in skeletal muscle, while a high-fat diet enhances mitochondria's ability to oxidize both long- and short-chain fatty acids. Researchers found that short-chain fatty acids—produced by gut microbiota and peroxisomal metabolism—can indeed fuel mitochondrial oxidative phosphorylation in muscle tissue. The study highlights how different lifestyle factors distinctly shape mitochondrial function: exercise expands mitochondrial numbers, whereas high-fat intake improves their metabolic versatility. These findings deepen our understanding of how diet and physical activity influence energy metabolism at the cellular level. Source: The Journal of Physiology. [[TRANSITION]] New research from Liver International reveals that butyrate produced by Prevotella bacteria can inhibit CD8 T cells, offering a potential therapeutic pathway for metabolic associated steatohepatitis, or MASH. MASH is a severe form of fatty liver disease with no effective treatments, and this study highlights how gut microbiota and their metabolites—particularly short-chain fatty acids like butyrate—can influence both liver metabolism and immune responses. The findings suggest that Prevotella-derived butyrate may help ameliorate MASH by modulating immune activity in the liver. This adds to growing evidence that targeting the gut microbiome could be a promising strategy for treating liver diseases. [[TRANSITION]] The gut microbiota's metabolic products play a crucial role in regulating systemic physiological processes and contributing to diseases beyond the digestive system, according to a comprehensive review in Comprehensive Physiology. Key microbial metabolites including short-chain fatty acids, tryptophan derivatives, bile acids, and trimethylamine N-oxide act as molecular messengers that influence distant organs and tissues. These compounds can affect everything from immune function to cardiovascular health, demonstrating how gut bacteria communicate with the rest of the body through their metabolic byproducts. The review highlights how this "metabolic dialogue" between gut microbes and host tissues represents a fundamental mechanism linking intestinal health to systemic disease processes. [[TRANSITION]] A new study in Environmental Microbiology uses Hi-C proximity ligation to map viral-host interactions in oxygen-deficient zones of the eastern tropical North Pacific. These zones are critical for global nitrogen cycling, yet most microbes and viruses there remain uncultivated. By linking viral genomes to their hosts in situ, the researchers uncovered active viral infections within the free-living microbial community of a secondary chlorophyll maximum. This approach reveals ecological roles of viruses in nitrogen removal processes like denitrification and anammox, offering new insights into microbial dynamics in these poorly understood environments. The findings highlight the power of Hi-C for studying uncultivated microbes and their viral predators in key ocean ecosystems. [[TRANSITION]] New research in the Journal of Neurochemistry reveals that blocking the NLRP3 inflammasome with the drug MCC950 can improve gut health in Huntington's disease mice. Huntington's disease is a genetic neurodegenerative disorder caused by a mutation in the huntingtin gene, leading to expanded polyglutamine repeats in the protein. The study, led by researchers who first identified gut microbial disruption in HD, shows that MCC950 treatment reduces inflammation and restores gut microbial balance in mouse models. This suggests that targeting the NLRP3 inflammasome could be a promising therapeutic strategy for managing gastrointestinal dysfunction in HD patients. The findings highlight the growing recognition of the gut-brain axis in neurodegenerative diseases and open new avenues for treatment. [[TRANSITION]] A new review in *International Immunopharmacology* explores how the gut-spinal axis links the gut microbiome to immune and metabolic changes after spinal cord injury. SCI triggers complex immune responses and metabolic dysregulation that impair recovery, and emerging evidence suggests the gut microbiome plays a key role in this process. The gut-spinal axis acts as a bidirectional communication pathway, influencing inflammation, immune cell activity, and metabolic homeostasis in the injured spinal cord. Understanding these interactions could open new avenues for therapies targeting the microbiome to improve outcomes after SCI. The review highlights the need for further research into how modulating gut bacteria might support functional recovery and quality of life for SCI patients. [[TRANSITION]] Animals act as "mobile bioreactors," ingesting microbes from different environments and mixing them into new microbial communities, a process called microbiome community coalescence. This understudied ecological phenomenon occurs at the animal-environment interface, where animals transport and combine separate microbial communities, potentially reshaping ecosystem functions. Researchers propose that by moving across landscapes, animals facilitate the blending of distinct microbiomes, creating novel microbial assemblages. This process could have significant implications for understanding how microbial diversity and ecosystem dynamics are influenced by animal movement. The study, published in Environmental Microbiology, highlights the need for further research into how animals contribute to microbial community coalescence and its broader ecological impacts. [[TRANSITION]] A new study in Environmental Microbiology Reports reveals that traditional abundance-based methods can miss the true drivers of freshwater ecosystem function. By integrating transcriptomic activity data with network analysis, researchers identified keystone microbes that are functionally critical but not necessarily the most abundant. This approach highlights how oxygen dynamics in lakes shape microbial communities, with active but rare species playing outsized roles in nutrient cycling and ecosystem stability. The findings challenge conventional microbiome studies that equate high abundance with ecological importance, suggesting that activity-informed metrics are essential for understanding microbial contributions to freshwater health. This work could reshape how scientists monitor and manage lake ecosystems, emphasizing functional potential over sheer numbers. [[TRANSITION]] A new study in *Biotechnology and Bioengineering* reveals that microbial communities in activated sludge can resist nano-silver stress by regulating N-acyl homoserine lactones-mediated quorum sensing. As nano-silver increasingly enters wastewater treatment plants, it threatens the microbial communities essential for efficient treatment. The research shows that quorum sensing—a bacterial communication system—can enhance tolerance to this environmental stressor. While the full mechanisms remain under investigation, the findings suggest that manipulating QS pathways could help protect wastewater treatment systems from nano-silver contamination. This work highlights the potential for leveraging natural microbial defense mechanisms to maintain treatment efficiency in the face of emerging pollutants. [[TRANSITION]] Metaproteomics researchers now have a new tool to improve species identification in complex microbial communities. The Peptonizer2000, introduced in the Journal of Proteome Research, addresses a key challenge in the field: accurately identifying species when protein sequences are highly similar across different organisms. Traditional methods often rely on simple counting of protein-taxon matches, which can lead to low accuracy. The Peptonizer2000 offers a more sophisticated approach to this problem, though specific technical details weren't provided in the available abstract. This tool represents an important advancement for scientists studying microbial communities through protein analysis, potentially leading to more reliable identification of species in complex environmental samples. [[TRANSITION]] A new study in *Biomedical Chromatography* explores how changes in gastric juice microbiota may be linked to bile acid metabolism in chronic atrophic gastritis. Researchers used antibiotic-mediated microbiota depletion in a rat model to investigate the role of gastric microecology, which has been understudied compared to intestinal flora. The findings suggest that dysbiosis in gastric juice is associated with abnormal bile acid profiles in chronic atrophic gastritis, pointing to a potential microbial influence on disease progression. This work highlights the importance of examining local gastric microbiota, not just gut bacteria, in understanding and potentially treating CAG. The study opens new avenues for targeting gastric microecology in managing chronic atrophic gastritis. [[TRANSITION]] New research in Hypertension reveals that bacterial extracellular vesicles from the gut can travel through the bloodstream and directly influence blood pressure regulation in male rats. Scientists identified these vesicles—tiny membrane-bound packages released by gut bacteria—in circulation and found they play a role in modulating cardiovascular function. The study suggests that changes in gut microbiota composition may contribute to hypertension by altering the production or content of these bacterial vesicles. This discovery highlights a previously unrecognized mechanism of microbiota-host communication, where bacterial vesicles act as molecular messengers affecting distant organs like the heart and blood vessels. These findings open new avenues for understanding how gut bacteria impact cardiovascular health and could inform future therapies targeting the microbiome to manage high blood pressure. References: [1] Metatranscriptomic Insights into Bacterial Activity, Virulence, and Antimicrobial Resistance in the Root Canal Microbiome of Acute Apical Abscesses. — PubMed — Journal of endodontics — https://doi.org/10.1016/j.joen.2026.01.002 [2] Unbinned contigs expand known diversity in the global microbiome. — PubMed — Nature microbiology — https://doi.org/10.1038/s41564-026-02314-6 [3] Gut microbiota-driven IL-17/PPAR axis mediates epigallocatechin-induced intestinal repair in weaned lambs. — PubMed — Journal of animal science and biotechnology — https://doi.org/10.1186/s40104-026-01371-5 [4] Planetary microbiome structure and generalist-driven gene flow across disparate habitats. — PubMed — Cell — https://doi.org/10.1016/j.cell.2025.12.051 [5] Gut microbiota-associated nutritional-immune status predicts prognosis in postoperative NSCLC patients. — PubMed — Gut microbes — https://doi.org/10.1080/19490976.2026.2652460 [6] Gut microbiota shifts in spaceflight: a case study evidence and countermeasures for microbial homeostasis. — PubMed — 3 Biotech — https://doi.org/10.1007/s13205-026-04760-9 [7] Metagenomic insights into the global wild boar faecal microbiome reveal novel taxa and carbohydrate degraders distinguishing wild and domesticated Sus. — PubMed — Microbiome — https://doi.org/10.1186/s40168-026-02392-y [8] Microbiome-Based Clustering Identifies Glycemic Control-Related Subtypes in Youth With Recent-Onset Type 1 Diabetes. — PubMed — MedComm — https://doi.org/10.1002/mco2.70705 [9] Gordonibacter-associated regulatory T cell dysfunction and S100A11-mediated neural impairment in Hirschsprung's disease: a microbiota-immune-neural axis. — PubMed — Cell & bioscience — https://doi.org/10.1186/s13578-026-01562-7 [10] The MicrobeAtlas database: Global trends and insights into Earth's microbial ecosystems. — PubMed — Cell — https://doi.org/10.1016/j.cell.2026.01.021 [11] Serum Sodium and Gut Klebsiella Are Positively Related to Osteoporosis. — PubMed — Cell biochemistry and function — https://doi.org/10.1002/cbf.70207 [12] From Field Metagenomes to Mutant Genomes: Coevolution of Cyanophages and — PubMed — Environmental science & technology — https://doi.org/10.1021/acs.est.5c12277 [13] Short-Chain Fatty Acids Activate Myenteric Neurons and Delay Colonic Motility via Free Fatty Acid Receptors 2 and 3 in the Mouse. — PubMed — Neurogastroenterology and motility — https://doi.org/10.1111/nmo.70299 [14] Microbial regulation of intestinal stem cell function: implications for alleviating intestinal injury of weaned piglets. — PubMed — NPJ biofilms and microbiomes — https://doi.org/10.1038/s41522-026-00973-1 [15] Human fecal transplantation from stunted children promotes metabolic dysfunction in mice fed with a high-fat and high-fructose corn syrup diet. — PubMed — Gut microbes — https://doi.org/10.1080/19490976.2026.2651984 [16] Neglected kingdoms: the gut virome, mycobiome and their role in inflammatory bowel disease. — PubMed — Gut microbes — https://doi.org/10.1080/19490976.2026.2653288 [17] Integrated analysis reveals strong reproducible signals within and across studies of the built environment — bioRxiv — microbiology — https://www.biorxiv.org/content/10.64898/2026.04.03.716326 [18] StrataBionn: a neural network supervised classification method for microbial communities — bioRxiv — genomics — https://www.biorxiv.org/content/10.64898/2026.03.31.715659 [19] Changes in dysbiosis and gene expression in the gut of wharf roach (Ligia Spp.) fed with expanded polystyrene — bioRxiv — pharmacology and toxicology — https://www.biorxiv.org/content/10.64898/2026.03.31.715705 [20] Microbiota-driven mechanisms in multisystem diseases: integrative evidence across cardiovascular, metabolic, neurological and autoimmune disorders. — PubMed — Antonie van Leeuwenhoek — https://doi.org/10.1007/s10482-026-02296-9 [21] Machine learning-based assessment of the healthy human gut mycobiota landscape using ITS1 DNA metabarcoding data. — PubMed — BioData mining — https://doi.org/10.1186/s13040-026-00532-6 [22] A diagnostic model based on pulmonary microbiota and host gene expression to distinguish colonization from pneumonia. — PubMed — Scientific reports — https://doi.org/10.1038/s41598-026-44972-w [23] Probiotic novel strain Lactobacillus reuteri MRD01 alleviates dextran sulfate sodium-induced colitis in male mice by promoting intestinal barrier integrity. — PubMed — Antonie van Leeuwenhoek — https://doi.org/10.1007/s10482-026-02291-0 [24] Sheng Jiangsan alleviated influenza-induced acute lung injury by regulating Lactobacillus murinus. — PubMed — Journal of ethnopharmacology — https://doi.org/10.1016/j.jep.2026.121524 [25] Microcystin-LR disrupts gut metabolic homeostasis through microbiota-metabolite axis remodeling in grass carp. — PubMed — Comparative biochemistry and physiology. Toxicology & pharmacology : CBP — https://doi.org/10.1016/j.cbpc.2026.110524 [26] Disrupted Salivary Fungal Community in Patients With Oral Lichen Planus. — PubMed — International dental journal — https://doi.org/10.1016/j.identj.2026.109546 [27] Atractylodes macrocephala polysaccharide AMP1-1 ameliorates weightless-induced cognitive dysfunction via the microbiota-gut-brain axis. — PubMed — International journal of biological macromolecules — https://doi.org/10.1016/j.ijbiomac.2026.151754 [28] Probiotic potential of Parabacteroides johnsonii in mitigating age-related ovarian functional decline. — PubMed — Journal of genetics and genomics = Yi chuan xue bao — https://doi.org/10.1016/j.jgg.2026.03.023 [29] Exercise training induces mitochondrial biogenesis, while high-fat diet increases the ability of mitochondria to use long and short-chain fatty acids. — PubMed — The Journal of physiology — https://doi.org/10.1113/JP289545 [30] Prevotella-Derived Butyrate Inhibits CD8 — PubMed — Liver international : official journal of the International Association for the Study of the Liver — https://doi.org/10.1111/liv.70613 [31] The Metabolic Dialogue Between the Gut and Distant Organs: From Microbial Products to Host Responses. — PubMed — Comprehensive Physiology — https://doi.org/10.1002/cph4.70127 [32] Hi-C Links Reveal Viral Activity and Infection Within the Free-Living Microbial Community of a Secondary Chlorophyll Maximum in the Eastern Tropical North Pacific. — PubMed — Environmental microbiology — https://doi.org/10.1111/1462-2920.70274 [33] Inhibition of the NLRP3 Inflammasome With MCC950 Improves Gut Health in Huntington's Disease Mice. — PubMed — Journal of neurochemistry — https://doi.org/10.1111/jnc.70419 [34] The role of the gut-spinal axis in immune-metabolic coupling after spinal cord injury. — PubMed — International immunopharmacology — https://doi.org/10.1016/j.intimp.2026.116581 [35] Bioreactors on the Move: How Animals Contribute to Microbial Community Coalescence and Shape Ecosystem Function. — PubMed — Environmental microbiology — https://doi.org/10.1111/1462-2920.70291 [36] Activity-Informed Network Analysis Reveals Keystone Microbes Shaping Freshwater Ecosystem Function. — PubMed — Environmental microbiology reports — https://doi.org/10.1111/1758-2229.70245 [37] Resistance of Microbial Community in Activated Sludge to Nano-Ag Stress Through Regulation of N-Acyl Homoserine Lactones-Mediated Quorum Sensing. — PubMed — Biotechnology and bioengineering — https://doi.org/10.1002/bit.70155 [38] The Peptonizer2000: Bringing Confidence to Metaproteomics. — PubMed — Journal of proteome research — https://doi.org/10.1021/acs.jproteome.5c00567 [39] Antibiotic-Mediated Microbiota Depletion Suggests an Association Between Gastric Juice Dysbacteriosis and Abnormal Bile Acid Metabolism in Chronic Atrophic Gastritis Rats. — PubMed — Biomedical chromatography : BMC — https://doi.org/10.1002/bmc.70404 [40] Bacterial Extracellular Vesicles Mediate Microbiota-Host Communication to Regulate Blood Pressure in Male Rats. — PubMed — Hypertension (Dallas, Tex. : 1979) — https://doi.org/10.1161/HYPERTENSIONAHA.125.25962